跳至主要内容
临床试验/CTRI/2023/08/056952
CTRI/2023/08/056952尚未招募1 期

A Randomised Open Labelled Controlled Clinical Study to evaluate the efficacy of Dhanyamla Dhara in Diabetic Neuropathy - NI

DR VAIDYANATH V.S0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Metabolically stable diabetic subjects with symptomatic Diabetic Peripheral Neuropathy.
  • 2.Subjects of all gender between the age group of 30-65 years.
  • 3.Subjects fulfilling the diagnostic criteria.
  • 4.Subjects whose HbA1C is between 6.5 to 10%.

排除标准

  • 1.Subjects where HbA1C >10% and <6.5%.
  • 2.Subjects suffering from Type-1 Diabetes or Gestational Diabetes.
  • 3.Pregnant and lactating women.
  • 4.Subjects suffering from infectious diseases and non-healing ulcer/ ulcers of foot.
  • 5.Any systemic illness that can interfere with the course of treatment.

研究者

发起方
DR VAIDYANATH V.S

相似试验